Related Tags >> Shionogi Sciele Pharma FDA drug safety

Japan News

Most Popular Japan Story

It's Merck v. Glaxo in vaccine battle

October 4, 2007 — 6:59am ET

Call it the battle of the HPV vaccines. For the past week, either Merck's Gardasil or GlaxoSmithKline's Cervarix--or both--have captured headlines: • Glaxo submits Cervarix for approval in Japan... Read more...

Japan Press Releases

Shire Announces Opening of Office in Japan
Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin
Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b)
MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production
Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal

Latest Headlines

Japan barreling toward its own patent cliff
May 19, 2009
Roche's Actemra linked to 15 deaths
March 18, 2009
Sciele enjoys six-year stock high
September 3, 2008
Japanese pharma to pay $1.4B for Sciele
September 2, 2008
Teva seeks venture partner in Japan
July 29, 2008
Roche warns of Tamiflu psych effects
March 5, 2008
Japan changes scrips to favor generics
November 9, 2007
SPOTLIGHT: Merck KGaA leads team to sell Erbitux in Japan
October 17, 2007
It's Merck v. Glaxo in vaccine battle
October 4, 2007
Pfizer plots spinoff of Japanese R&D
September 21, 2007

Paid Research Reports

More Research Reports >>